Sagility India IPO Day 1 Subscription Hits 0.10 Times as of 12:01 PM

Sagility India IPO, one of the upcoming IPO in India, opened for subscription today on November 5, 2024, and will close on November 7, 2024. The allotment is expected to be finalised on Friday, November 8, 2024. The IPO will be listed on both BSE and NSE, with a tentative listing date set for Tuesday, November 12, 2024.

This IPO is a book-built issue valued at ₹2,106.60 crore, consisting entirely of an offer for sale involving 70.22 crore shares.

The price band for the Sagility India IPO is set between ₹28 and ₹30 per share. Retail investors must apply for a minimum lot size of 500 shares, requiring a minimum investment of ₹15,000. Additionally, the issue reserves up to 19,00,000 shares for employees at a discount of ₹2 per share from the issue price.

The objectives of the offers are to achieve the benefits of listing the equity shares on the stock exchanges and to carry out the offer for sale of up to 702,199,262 equity shares of the face value of ₹10 each by the promoter selling shareholder.

As of November 5, 2024, at 09:26 AM, the last Sagility India IPO GMP is ₹0.

Sagility India IPO Subscription Status

On Day 1, November 5, 2024, at 12:01 PM, Sagility India IPO was subscribed 0.10 times overall. The retail category was subscribed at 0.51 times, QIB at 0.00 times, and NII at 0.03 times, while the employee category stands at 0.59 times. 

About Sagility India Limited

The company specialises in providing technology-enabled business solutions and services tailored to the U.S. healthcare industry. As a pure-play provider focused on healthcare services, Sagility’s clientele includes payers (U.S. health insurance companies that finance and reimburse health service costs) and providers (primarily hospitals, physicians, and companies in diagnostics and medical devices).

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.